Your Catalyst to a Lucrative Business
Liquid Biopsy Market Share, Size, Key Players, Research and
Forecasts to 2025 | Hexa Research
“ The global liquid biopsy market is projected to witness substantial growth
over the forecast period.”
28 December 2018
The global liquid biopsy market is projected to witness substantial growth over the forecast period (from
2017 to 2025) owing to advancement in liquid biopsy tests and extensive R&D by major companies. Liquid
biopsy is a highly effective and non-invasive technology that offers an enhanced view of the tumor. It helps
detect the presence of cancer before any substantial tumor formation and access multiple mutations in the
tumor. Increasing number of successful test trials and efficiency in all cancer related investigation are also
projected to drive the market. Moreover, highly invasive nature and frequent complications associated with
tissue biopsy and advancements in Next-Generation Sequencing (NGS) is anticipated to fuel demand for
liquid biopsy in coming years.
Liquid biopsies make use of bio fluid samples, such as blood, urine sample, tissue fluids, and saliva. The
technology is widely used in molecular health monitoring, therapy selection for Metastatic Breast Cancer
(MBS), and other related cancers. Moreover, it is also used as a molecular monitoring diagnostic tool for
other illnesses that can be examined using bio fluids for cancer recurrence, patient screening, and other
related investigation. MBS is likely to emerge as a leading application over the forecast period as a result of
growing cases of metastatic cancer across the world. Single and multi-gene analysis are the two major
methods employed for diagnosis. PCR-based sequencing is used for analysis of mutations in disease-specific
genes, whereas NGS testing is used for simultaneous analysis of multiple diseases. Rising awareness about
Follow Us: